NCT05859633

Brief Summary

Acute pancreatitis (AP) is a disease characterized by dysfunction of pancreatic acinar cells, improper activation of trypsin, and subsequent destruction of pancreatic self-defense mechanisms, further exacerbating injury and damage of pancreatic cells. It is a rapidly developing inflammatory process of the pancreas, and the most common reasons are alcohol and gallstones.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 16, 2023

Completed
14 days until next milestone

Study Start

First participant enrolled

May 30, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

May 16, 2023

Status Verified

May 1, 2023

Enrollment Period

7 months

First QC Date

May 4, 2023

Last Update Submit

May 5, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • severe acute pancreatitis

    frequency of severe acute pancreatitis

    one year

Study Arms (1)

patients with acute pancreatitis

any patient suffers from acute pancreatitis

Diagnostic Test: Neutrophil/Lymphocyte Ratio in acute pancreatitis

Interventions

role of Neutrophil/Lymphocyte Ratio in acute pancreatitis

patients with acute pancreatitis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Any patient who is above age of 18 years old and diagnosed to have AP. Patients were diagnosed with acute pancreatitis if more than 2 of the following conditions were satisfied: 1) abdominal pain consistent with acute pancreatitis (acute onset of a persistent, severe, epigastric pain often radiating to the back); 2) serum amylase and/or lipase level at least 3 times greater than the upper limit of the normal value; and 3) characteristic manifestation of acute pancreatitis on contrast-enhanced computed tomography, magnetic resonance imaging, or transabdominal ultrasonography

You may qualify if:

  • patients with acute pancreatitis

You may not qualify if:

  • Patients with acute abdomen with diagnosis other than AP
  • Patients with AP who are under age of 18 years old
  • Patient's refusal

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed Mohammed Abu-Elfatth

Asyut, 71515, Egypt

RECRUITING

Related Publications (1)

  • Mederos MA, Reber HA, Girgis MD. Acute Pancreatitis: A Review. JAMA. 2021 Jan 26;325(4):382-390. doi: 10.1001/jama.2020.20317.

    PMID: 33496779BACKGROUND

MeSH Terms

Conditions

Pancreatitis

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System Diseases

Study Officials

  • Ahmed M Abu-Elfatth

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ahmed M Abu-Elfatth

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Internal Medicine

Study Record Dates

First Submitted

May 4, 2023

First Posted

May 16, 2023

Study Start

May 30, 2023

Primary Completion

December 30, 2023

Study Completion

December 31, 2023

Last Updated

May 16, 2023

Record last verified: 2023-05

Locations